Emerging COVID-19 neurological manifestations: present outlook and potential neurological challenges in COVID-19 pandemic

S Dewanjee, J Vallamkondu, RS Kalra… - Molecular …, 2021 - Springer
The unremitting coronavirus disease 2019 (COVID-19) pandemic caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase …

Vaccination and multiple sclerosis in the era of the COVID-19 pandemic

T Monschein, HP Hartung, T Zrzavy… - Journal of Neurology …, 2021 - jnnp.bmj.com
In the last century, several pandemics were caused by various influenza virus subtypes, with
the Spanish influenza of 1918–1920 being the most severe. 1 Coronaviruses were first …

A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases

Z Hamidi, S Jabraeili-Siahroud, Y Taati-Alamdari… - Virology Journal, 2023 - Springer
After the first reporting of the index case of Severe Acute Respiratory Syndrome (SARS)-CoV-
2-associated disease at the end of December 2019, the virus spread quickly throughout the …

Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies—the Polish experience

A Czarnowska, W Brola, O Zajkowska… - Neurologia i …, 2021 - journals.viamedica.pl
Introduction. The aim of this study was to report the course and outcome of SARS-CoV-2
infection in multiple sclerosis (MS) patients treated with disease-modifying therapies (DMTs) …

COVID‐19 and inflammatory bowel disease crosstalk: from emerging association to clinical proposal

SS Tao, XY Wang, XK Yang, YC Liu… - Journal of medical …, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection can cause
coronavirus disease 2019 (COVID‐19), an acute respiratory inflammation that has emerged …

Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches

M Mahboubi Mehrabani, MS Karvandi… - Reviews in medical …, 2022 - Wiley Online Library
With the progression of investigations on the pathogenesis of severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), neurological complications have emerged as a …

Safety, immunogenicity, efficacy, and acceptability of COVID-19 vaccination in people with multiple sclerosis: a narrative review

F Capone, M Rossi, A Cruciani… - Neural Regeneration …, 2023 - journals.lww.com
In the last two years, a new severe acute respiratory syndrome coronavirus (SARS-CoV)
infection has spread worldwide leading to the death of millions. Vaccination represents the …

Multiple sclerosis and COVID-19: A retrospective study in Iran

B Sedighi, A Haghdoost, P Jangipour Afshar, Z Abna… - Plos one, 2023 - journals.plos.org
Objectives Previous studies suggested a higher rate of COVID-19 infection in patients with
multiple sclerosis than in the general population, and limited studies addressed the impact …

Impact of the COVID‐19 pandemic on access to healthcare services amongst patients with multiple sclerosis in the Lazio region, Italy

P Colais, S Cascini, M Balducci… - European Journal of …, 2021 - Wiley Online Library
Background and purpose Multiple sclerosis (MS) is a complex chronic, autoimmune
inflammatory disease involving multidisciplinary assessments and interventions. Access to …

Update on cerebrovascular manifestations of COVID-19

R Naeimi, M Ghasemi–Kasman - Neurological Sciences, 2020 - Springer
The novel member of coronaviruses family, severe acute respiratory coronavirus-2 (SARS-
CoV-2), with high structural homology to SARS-CoV and Middle East respiratory syndrome …